Catalog
BrandsLa Roche-Posay Anthelios UVmune 400 Hydrating Cream SPF50 +, Sunscreen Moisturizing Cream, with Color 50ml
La Roche-Posay Anthelios UVmune 400 Hydrating Cream SPF50 +, Sunscreen Moisturizing Cream, with Color 50ml
ANTHELIOS UVMUNE 400 HYDRATING CREAM SPF50 + WITH COLOR: With MEXORYL400, the most effective sunscreen against the most harmful UV rays: ULTRA LONG UVA *. Absolute protection (UVB + UVA + ULTRA LONG UVA) against deep cell damage. Tested on sensitive, reactive and intolerant skin. Suitable for all skin types, all phototypes.
Extremely durable: in water and sand. Optimal tolerance. It does not sting the eyes. Invisible, moisturizing texture. With hypoallergenic aroma.
APPLICATION:
For daily use and sun exposure. Apply the sunscreen just before exposure. Apply regularly and generously to maintain a level of protection, especially after sweating or wiping with a towel.
TEXTURE
Invisible finish. Non-greasy. Non-stick.
With La Roche-Posay Thermal Water.
KEY BENEFITS
For sensitive or reactive skin. Also suitable for skin allergic to the sun.
Can be applied around the eyes. It does not sting the eyes. Hypoallergenic.
For more than 25 years, Anthelios has been a pioneer in major innovations: UVA filters, broadband protection, textures and technologies. For all skin types, all phototypes.
SCIENCE BEHIND THE PRODUCT
XL-PROTECT: A patented filter technology, provides very high broadband protection from UVB / UVA and helps protect against damage caused by pollution and infrared radiation.
MEXORYL400: a new exclusive UV filter that protects against even the most harmful UV rays: ULTRA LONG UVA * up to 400nm.
With NETLOCK TECHNOLOGY for Absolute protection, extremely durable in an invisible texture.
Tested under dermatological control on sensitive and reactive skin.
Tested under ocular examination on sensitive eyes and eye contour. Tested on contact lens users.
Allergy tested.
La Roche-Posay sunscreen is recommended by 60,000 dermatologists worldwide *
* Source: Dermocosmetics Market Survey, conducted by AplusA and other partners during the period January 2021-July 2021, involving dermatologists in 34 countries, representing over 82% of world GDP
